Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HB-adMSCs for COVID-19 Immune Support
NCT04348435Phase 2Completed
- Sponsor
- Hope Biosciences
- Start
- May 2020
- Primary completion
- May 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic HB-adMSCs in coronavirus disease 2019 (COVID-19), sponsored by Hope Biosciences. Started May 2020; status: completed.
02
Drugs
allogeneic HB-adMSCs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04348435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04348435.